Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Stay Pausing Investments

Johnson & Johnson is an American multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceuticals. The company announced in November 2021 that it would split into two publicly traded companies: one focused on consumer products and the other on pharmaceuticals and medical technologies.

Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Stay Pausing Investments

Global 500, is an annual ranking of the top 500 corporations worldwide

Global 500

Top 100 largest companies in Russia by revenue

Top 100
Revenue(RF), mln.USD
809
Assets(RF), mln.USD
892
Capital(RF), mln.USD
601
Glob.Revenue, mln.USD
89011
Staff(RF), 2021
1625
Taxes(RF), mln.USD
204

The company has three regional offices. The American company Johnson & Johnson currently continues to supply Acuvue contact lenses to Russia. Johnson & Johnson's Russian subsidiary, Johnson & Johnson LLC, has liquidated its representative office in the Republic of Kazakhstan. Such changes have occurred in the Unified State Register of Legal Entities according to the information system for HONEST BUSINESS. Since the beginning of 2024, the company has been optimizing its structure. In February 2024, the Armenian and Belarusian representative offices were liquidated. At the end of July 2024, the company had one representative office in Georgia and one branch in Kazakhstan. The company probably plans to replenish the activities of the closed representative office in Kazakhstan through the remaining branch and the Kazakh "daughter" - Spectrum Vision LLP.

The Company Statement
May 30, 2023

The company suspended all advertising, enrollment in clinical trials, and any additional investment in Russia. It was decided to suspend supply of the personal care products in Russia. The company will continue to supply the medicines and medical devices in the region. Suppliers of Johnson & Johnson goods began to send notices to opticians about the suspension of imports.

July 31, 2024Russian Johnson & Johnson closed its representative office in Kazakhstan
April 12, 2024A collapse in supplies of Western medicines has begun in Russia
May 25, 2023Is there a shortage of contact lenses due to restrictions?
May 25, 2023Russia faces a shortage of contact lenses.
February 17, 2023In Russia, the range of hygiene products and household chemicals has sharply decreased after the departure of foreign brands
January 04, 2023Letter sent by B4Ukraine to the company (no response provided)
March 29, 2022Johnson & Johnson Statement on War in Ukraine
March 29, 2022Johnson & Johnson Halts Supply of Personal-Care Products in Russia
March 04, 2022Johnson & Johnson Statement on Conflict in Ukraine
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner